Intra-Cellular Therapies Inc. buy TD Cowen
Start price
18.04.24
/
50%
€68.50
Target price
18.04.25
€84.35
Performance (%)
5.84%
Price
23.07.24
€72.50
Summary
This prediction is currently active. With a performance of 5.84%, the BUY prediction by TD_Cowen for Intra-Cellular Therapies Inc. is trending in the right direction. This prediction currently runs until 18.04.25. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 0.000% | 0.000% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by TD_Cowen for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at TD Cowen from $80.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by TD_Cowen for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€55.30
11.12.23
11.12.23
€69.65
11.12.24
11.12.24
31.10%
23.07.24
23.07.24